All patients | Patients with past or current TB or treatment for LTBI | Patients with no past or current TB nor treatment for LTBI | |
---|---|---|---|
QFG *vs TST* | 0.548 | 0.524 | 0.437 |
(0.417-0.621) | (0.359-0.615) | (0.233-0.663) | |
T.SPOT.TB (Mc)* vs TST* | 0.397 | 0.415 | 0.238 |
(0.268-0.515) | (0.233-0.663) | (0.092-0.392) | |
T.SPOT.TB (FDAc)** vs TST* | 0.483 | 0.493 | 0.359 |
(0.339-0.609) | (0.249-0.685) | (0.176-0.541) | |
T.SPOT.TB (FDAc)*** vs TST* | 0.392 | 0.482 | 0.237 |
(0.269-0.500) | (0.243-0.665) | (0.100-0.372) | |
T.SPOT.TB (FDAc)**** vs TST* | 0.455 | 0.430 | 0.350 |
(0.315-0.583) | (0.186-0.622) | (0.171-0.533) | |
T.SPOT.TB (Mc)* vs QFG* | 0.365 | 0.331 | 0.324 |
(0.255-0.437) | (0.110-0.483) | (0.196-0.381) | |
T.SPOT.TB (FDAc)** vs QFG* | 0.478 | 0.456 | 0.426 |
(0.348-0.554) | (0.213-0.601) | (0.259-0.504) | |
T.SPOT.TB (FDAc)*** vs QFG* | 0.351 | 0.355 | 0.289 |
(0.250-0.411) | (0.143-0.477) | (0.171-0.341) | |
T.SPOT.TB (FDAc)**** vs QFG* | 0.464 | 0.447 | 0.414 |
(0.336-0.560) | (0.208-0.611) | (0.245-0.515) |